Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Merchants Group (CMG) is a leading state-owned conglomerate headquartered in Hong Kong, with core business interests in integrated transportation, financial services, and real estate development. The group has strategically expanded into the healthcare sector through its dedicated subsidiary, China Merchants Health Industry (Group), focusing on a comprehensive "Great Health" strategy. CMG's healthcare portfolio includes the management of medical institutions, health technology investments, and the development of specialized life science industrial parks. A notable aspect of its biotech involvement is the China Merchants AstraZeneca Healthcare Fund, a joint venture aimed at supporting innovative healthcare companies in China. The group also provides comprehensive logistics and supply chain solutions tailored for the pharmaceutical industry, leveraging its global infrastructure to foster innovation in biotechnology and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Merchants Group.